Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AVDL
#1632
Avadel Pharmaceuticals plc
21.640
0
+0.05%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+0.05%
Monthly Change
+0.70%
6 month change
+16.66%
Cambio anual
+16.66%
Cierres anteriores
21.630
0
Open
21.640
0
Bid
Ask
Low
21.640
0
High
21.640
0
Volumen
1 054
Markets
Acciones
Atención Sanitaria
AVDL
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
58.47 M
59.03 M
64.48 M
90.58 M
96.63 M
—
Valuation ratios
Enterprise value
—
—
—
—
964.2 M
3.87 B
Price to earnings ratio
—
—
—
—
-20.61
1 033.78
Price to sales ratio
—
—
—
—
5.91
19.71
Price to cash flow ratio
—
—
—
—
21.32
380.06
Price to book ratio
—
—
—
—
13.54
23.3
Enterprise value to EBITDA ratio
—
—
—
—
-22.81
—
Profitability ratios
Return on assets %
0.02
-0.31
-1.04
-0.97
-0.3
-0.11
Return on equity %
0.04
-0.99
-6.5
-1.83
-0.66
-0.24
Return on invested capital %
-18.66
-138.33
-237.71
-1 055.02
-455.01
-52.75
Gross margin %
74.29
—
—
96.97
90.97
375.8
Operating margin %
26.04
—
—
-492.97
-25.07
-13.27
EBITDA margin %
275.6
—
—
-482.06
-24.99
—
Net margin %
31.47
—
—
-573.17
-28.87
-32.31
Liquidity ratios
Quick ratio
17.44
—
—
3.36
2.33
9.42
Current ratio
17.44
9.17
1.81
3.64
2.75
11.03
Inventory turnover
3.22
—
—
0.16
1
0.65
Asset turnover
0.1
0
0
0.19
1.03
1.41
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.41
0.58
0.69
0
—
—
Long term debt to total equity ratio
0.79
1.82
4.33
0
—
—
Per share metrics
Operating cash flow per share
-0.89
-1.32
-1.17
-1.6
-0.49
0.35
EBIT per share
0.99
-0.17
—
-1.72
-0.45
0.04
EBITDA per share
1.12
-0.14
—
-1.68
-0.44
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.33
0.87
1.61
1.31
0.78
3.21
Net current asset value per share
4.8
3.29
1.68
1.67
1.41
6.19
Tangible book value per share
2.65
1.05
0.07
0.88
0.6
2.75
Working capital per share
4.52
2.93
0.75
1.21
0.9
3.94
Book value per share
2.95
1.34
0.35
1.09
0.78
3.44
Noticias
Próximos resultados de Alkermes mientras toma forma su estrategia en trastornos del sueño
Alkermes earnings up next as sleep strategy takes shape
Harmony Biosciences Makes The Grade (NASDAQ:HRMY)
UBS eleva precio objetivo de Alkermes a $47 tras acuerdo con Avadel
UBS eleva el precio objetivo de Alkermes a 47 dólares desde 46 dólares tras acuerdo con Avadel
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal
BlackRock revela una participación del 6,94% en Avadel Pharmaceuticals
BlackRock revela participación del 6.94% en Avadel Pharmaceuticals
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals
TIG Advisors revela una participación del 4,18% en Avadel Pharmaceuticals
TIG Advisors revela participación del 4.18% en Avadel Pharmaceuticals
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals